This meeting took place in 2012
Here are the related meetings in 2021:
Innovative Vaccine Approaches - RESCHEDULING TO VIRTUAL (Z5)
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
Immunological Mechanisms of Vaccination (S3)
Organizer(s) Adrian V.S. Hill, Dan H. Barouch, John T. Harty and Tania H. Watts
December 13—18, 2012
Fairmont Château Laurier • Ottawa, ON Canada
Abstract Deadline: Aug 13, 2012
Late Abstract Deadline: Sep 13, 2012
Scholarship Deadline: Aug 13, 2012
Early Registration Deadline: Oct 11, 2012
Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation
Summary of Meeting:
Vaccines are remarkably successful in reducing morbidity and mortality from infectious diseases in both developed and developing countries. However, globally, mortality from infectious disease still exceeds 10 million deaths annually, reflecting a need for new, more effective and more deployable vaccination approaches. As many of the relatively easy vaccines have already been made, vaccinology is now tackling more difficult diseases, often caused by complex and genetically variable pathogens. A better understanding of the immunological mechanisms underpinning existing and novel vaccines is therefore required. Fortunately, research efforts to uncover new molecular and cellular techniques offer exceptional opportunities for improved vaccine design. A better understanding of the immunology of vaccination will be of value in evidence-based design of new vaccines against major global causes of mortality such as HIV, malaria and tuberculosis, and against emerging infections such as swine influenza and dengue. Advances in immunology, genomics and systems biology are beginning to offer a deeper understanding of the molecular and cellular mechanisms of host immunity, and the pivotal role played by the innate immune system in shaping the adaptive immune response. This is providing new opportunities to identify new signatures of vaccine immunogenicity and protective efficacy, which should facilitate vaccine development and guide improved vaccine design. The Keystone Symposia meeting on Immunological Mechanisms of Vaccination will bring together an interdisciplinary group of scientists in vaccinology, immunology and pathogen biology, to address recent advances in these fields and their potential for accelerating vaccine design and development.
View Meeting Program
Vaccines are remarkably successful in reducing morbidity and mortality from infectious diseases in both developed and developing countries. However, globally, mortality from infectious disease still exceeds 10 million deaths annually, reflecting a need for new, more effective and more deployable vaccination approaches. As many of the relatively easy vaccines have already been made, vaccinology is now tackling more difficult diseases, often caused by complex and genetically variable pathogens. A better understanding of the immunological mechanisms underpinning existing and novel vaccines is therefore required. Fortunately, research efforts to uncover new molecular and cellular techniques offer exceptional opportunities for improved vaccine design. A better understanding of the immunology of vaccination will be of value in evidence-based design of new vaccines against major global causes of mortality such as HIV, malaria and tuberculosis, and against emerging infections such as swine influenza and dengue. Advances in immunology, genomics and systems biology are beginning to offer a deeper understanding of the molecular and cellular mechanisms of host immunity, and the pivotal role played by the innate immune system in shaping the adaptive immune response. This is providing new opportunities to identify new signatures of vaccine immunogenicity and protective efficacy, which should facilitate vaccine development and guide improved vaccine design. The Keystone Symposia meeting on Immunological Mechanisms of Vaccination will bring together an interdisciplinary group of scientists in vaccinology, immunology and pathogen biology, to address recent advances in these fields and their potential for accelerating vaccine design and development.
View Meeting Program
Scholarships/Awards
Biogen Scholarship Recipients
Melba Marie Tejera
University of Wisconsin, Madison, USA
Biogen Idec ECITA Scholarship Recipients
Dwain K. Morris-Irvin
StemVax Therapeutics, USA
Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation Recipients
Christoph J. Blohmke
University of Oxford, UK
Stephanie Soek Yeng Chan
Australian National University, JCSMR, Australia
Taryn L. Osmond
Malaghan Institute of Medical Research, New Zealand
Helene Perrin
INSERM U945 - Laboratory of Immunity and Infection, France
Jason M. Schenkel
Brigham and Women's Hospital, USA
National Institute of General Medical Sciences (NIGMS) Ancillary Training Program Scholarship Recipients
Pablo Penaloza-MacMaster
Northwestern University, USA
National Institute of Allergy and Infectious Diseases (NIAID) Scholarship Recipients
Jan Philipp Böttcher
University of Bonn, Germany
Achire Nathalia Mbanwi
University of Toronto, Canada
Pamela Marie Odorizzi
Vir Biotechnology, USA
Cara Skon
Genentech, Inc., USA
Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation
Mohamed S. Abdel-Hakeem
Université de Montréal (University of Montreal), Canada
Julius Atashili
University of Buea, Cameroon
Oluwole Adeyemi Babatunde
University of South Carolina, USA
Atmaram H. Bandivdekar
National Institute for Research in Reproductive Health, India
Silvia B. Boscardin
University of São Paulo, Brazil
John Martin Buwembo
Uganda Virus Research Institute, Uganda
Silvia Almeida Cardoso
Universidade Federal de Viçosa, Brazil
Ayan Dey
International Vaccine Institute, South Korea
Yakhya Dieye
Ecole Supérieure Polytechnique, Senegal
Liya Wassie Dubale
Armauer Hansen Research Institute, Ethiopia
Adedayo Omotayo Faneye
College of Medicine, University of Ibadan, Nigeria
Paola Fernanda Fedatto
University of São Paulo (USP), Brazil
Kathleen Korkor Marie Glover
University of Manitoba, Manitoba Centre for Proteomics and Systems Biology, Canada
Dawit Gebreegziabiher Hagos
Mekelle University, Ethiopia
Adaobi Jennifer Iheanyi
Health Issues Prevention and Assistance Organization, Nigeria
Ayorinde Babatunde James
College of Medicine-University of Lagos, Nigeria
Isaac Kayanja
Makerere Womens Hospital, Uganda
Asif Raza Khowaja
Aga Khan University, Pakistan
Altaye Habtegiorgis Kidane
ICAP Swaziland, Swaziland
Stephen Kiggundu
International AIDS Vaccine Initiative, Uganda
Macklyn Kihembo
Medical Research Council/Uganda Virus Research Institute, Uganda
Michael Muganga Kikonyogo
Makerere University School of Medicine, Uganda
Juliana Almeida Leite
University of Campinas, Brazil
Mpala Lisulo
Tropical Gastroenterology and Nutrition Group (TROPGAN), Zambia
Angelique Kany Kany Luabeya
University of Cape Town, South Africa
Mitala Charles Lwanga
Uganda Virus Research Institute, Uganda
Adedayo Olubunmi Makinde
University of Ibadan, Nigeria
Emilio Luis Malchiodi
Facultad de Farmacia y Bioquímica, Argentina
Sandra Regina Costa Maruyama
University of São Paulo, Brazil
Chiaka Mbakwem-Aniebo
University of Port Harcourt, Nigeria
Jomkhwan Meerak
Chiangmai University, Thailand
Maria Pilar Mejias
CONICET- Academia Nacional de Medicina, Argentina
Erick M. O. Muok
KEMRI, Kenya
Shem Steven Mwebaza
Mildmay Uganda, Uganda
Ritah Faith Nakiboneka
Uganda Virus Research Institute, Uganda
Meena Narayanan
Center of Pathophysiology, Infectiology and Immunology, Austria
Jamirah Nazziwa
Uganda Virus Research Institute, Uganda
Bagrey M. Ngwira
College of Medicine, Malawi
Nanuli Ninashvili
State Medical University; NCDC, Georgia
Fatou Noho-Konteh
Medical Research Council, Fajara, Gambia
Matthew Obaineh Ojezele
Delta State University, Abraka, Nigeria
Ewa Oleszycka
Trinity Biomedical Sciences Institute, Ireland
Joseph Omololu-aso
Obafemi Awolowo University, Nigeria
Murtada Ahmed Osman
Preventive Medicine Directorate, Sudan
Jorge Alberto Panameno
Fundacion Salvadorena para la Inmunoinfectologia y Medicina Tropical, El Salvador
Ayodhia Pitaloka Pasaribu
Sumatera Utara University, Indonesia
Md Sahidur Rahman
James P Grant School of Public Health, BRAC University, Bangladesh
Ismail Sebina
QIMR Berghofer Medical Research Institute, Australia
Elichilia R. Shao
Kilimanjaro Christian Medical University College, Tanzania
Anshuman Shukla
IDS Infotech Ltd., India
Sengeziwe Sibeko
University of Oxford, UK
Zegabriel Tedla
Centers for Disease Control; Botswana, Botswana
Ishaya S. Tekki
National Veterinary Research Institute, Nigeria
Yenenesh Kelile Tekletsion
Armauer Hansen Research Institute, Ethiopia
Pratibha Thapa
Leprosy Mission Nepal, Nepal
Mala Upadhyay
Center for Cellular and Molecular Biology, India
Cintia Fiuza Marques Vadesilho
Instituto Butantan, Brazil
Phonphimon Wongthida
National Center of Genetic Engineering and Biotechnology, Thailand
Surangi Gayanitha Yasawardene
University of Sri Jayewardenepura, Sri Lanka
Fang Yu
Affiliated Hospital of Guiyang Medical College, China
Qing Zhu
Chinese Academy of Medical Sciences/Peking Union Medical College, China
